Hd-Ivus
Payments companies reported to CMS as associated with Hd-Ivus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hd-Ivus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hd-Ivus
These are the largest totals companies reported as associated with Hd-Ivus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Allen Jeremias | E Setauket, NY | Cardiovascular Disease | $19,083.02 |
| Morton Kern | Orange, CA | Cardiovascular Disease | $8,000.00 |
| Lauren Richards | Phoenix, AZ | Interventional Cardiology | $5,950.94 |
| Evan Shlofmitz | Roslyn, NY | Interventional Cardiology | $5,111.33 |
| Vamsi Krishna | Kyle, TX | Interventional Cardiology | $5,053.20 |
| Jeffrey Wilson | Fenton, MO | Interventional Cardiology | $4,224.92 |
| Gregory Helmer | Edina, MN | Interventional Cardiology | $3,150.00 |
| Paul Teirstein | La Jolla, CA | Interventional Cardiology | $599.79 |
| Ziad Ali | New York, NY | Internal Medicine | $501.47 |
| Darshan Doshi | Boston, MA | Interventional Cardiology | $473.58 |
Prescribed Hd-Ivus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.